Loco-regional interventional treatment of hepatocellular carcinoma: Techniques, outcomes, and future prospects

Transplant International

Volumn 23, Issue 7, 2010, Pages 698-703

  Lencioni, Riccardo ^a   Crocetti, Laura ^a   De Simone, Paolo ^a   Filipponi, Franco ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Hepatocellular carcinoma; Image guided ablation; Molecular targeted therapies; Transarterial chemoembolization

Indexed keywords

ALCOHOL; APTOCINE; DOXORUBICIN; IODINATED POPPYSEED OIL; IODINE 131; TALAPORFIN; UNCLASSIFIED DRUG; YTTRIUM 90;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; ELECTROPORATION; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MICROWAVE THERAPY; MOLECULAR THERAPY; MOLECULARLY TARGETED THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SAFETY; SUSTAINED RELEASE PREPARATION; TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR GROWTH; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPUTER ASSISTED SURGERY; ELECTROCHEMOTHERAPY; LIVER NEOPLASMS; MICROWAVE RADIATION; PROCEDURES; THERAPEUTIC USE; TUMOR RECURRENCE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; ELECTROCHEMOTHERAPY; ETHANOL; HUMANS; LIVER NEOPLASMS; MICROWAVES; NEOPLASM RECURRENCE, LOCAL; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 77953184336     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01109.x     Document Type: Conference Paper

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74.
2. Bruix J, Sherman M, Llovet JM, et al. EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001 35 : 421.
3. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005 42 : 1208.
4. Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet 2009 373 : 614.
5. Llovet JM, Di Bisceglie AM, Bruix J, et al. Panel of experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008 100 : 698.
6. Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 2007 10 : 38.
7. Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Crit Rev Oncol Hematol 2008 66 : 200.
8. Lencioni R, Bartolozzi C, Caramella D, et al. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients. Cancer 1995 76 : 1737.
9. Lencioni R, Pinto F, Armillotta N, et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience. Eur Radiol 1997 7 : 514.
10. Khan KN, Yatsuhashi H, Yamasaki K, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000 32 : 269.
11. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000 88 : 529.
12. Lu MD, Kuang M, Xie XY, et al. Percutaneous ethanol ablation of early-stage hepatocellular carcinoma by using a multi-pronged needle with single treatment session and high-dose ethanol injection. Radiology 2009 253 : 552.
13. Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003 228 : 235.
14. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004 127 : 1714.
15. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005 129 : 122.
16. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005 54 : 1151.
17. Brunello F, Veltri A, Carucci P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 2008 43 : 727.
18. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009 104 : 514.
19. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009 49 : 453.
20. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006 243 : 321.
21. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005 234 : 954.
22. Ebara M, Okabe S, Kita K, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005 43 : 458.
23. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002 223 : 331.
24. Al-Sakere B, André F, Bernat C, et al. Tumor ablation with irreversible electroporation. PLoS ONE 2007 2 : e1135.
25. Wang S, Keltner L, Winship J, Lee W. A phase 1/2 safety and efficacy study of intratumoral light-activated drug therapy using talaporfin sodium in patients with inoperable hepatocellular carcinoma. J Clin Oncol 2009 27, suppl; abstract e15684.
26. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003 37 : 429.
27. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002 359 : 1734.
28. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002 35 : 1164.
29. Varela M, Real MI, Burrel M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007 46 : 474.
30. Lammer J, Malagari K, Vogl T, et al. Prospective randomised study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010 33 : 41.
31. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 2005 234 : 961.
32. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008 359 : 378.
33. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009 10 : 25.
34. Wang B, Xu H, Gao ZQ, et al. Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization. Acta Radiol 2008 49 : 523.
35. Virmani S, Rhee TK, Ryu RK, et al. Comparison of hypoxia-inducible factor-1alpha expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol 2008 19 : 1483.